StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)

Close on Nov 18, 2026Market cap $248.90MP/E –Yield –

Amarin operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Amarin's operating income for the twelve months ending Sep 30, 2026 was -$32.03M. For fiscal 2025 it was -$50.17M. The highest annual figure on record is $10.50M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$50.17M–
FY2024Dec 31, 2024-$91.80M–
FY2023Dec 31, 2023-$67.59M–
FY2022Dec 31, 2022-$105.87M-1108.1%
FY2021Dec 31, 2021$10.50M–
FY2020Dec 31, 2020-$19.66M–
FY2019Dec 31, 2019-$24.28M–
FY2018Dec 31, 2018-$108.23M–
FY2017Dec 31, 2017-$45.56M–
FY2016Dec 31, 2016-$65.63M–
FY2015Dec 31, 2015-$98.22M–
FY2014Dec 31, 2014-$95.96M–
FY2013Dec 31, 2013-$182.11M–
FY2012Dec 31, 2012-$116.75M–
FY2011Dec 31, 2011-$44.16M–
FY2010Dec 31, 2010-$45.10M–
FY2009Dec 31, 2009-$34.04M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$2.36M–
Q2 FY2026Jun 30, 2026-$12.01M–
Q1 FY2026Mar 31, 2026-$11.33M–
Q4 FY2025Dec 31, 2025-$6.33M–
Q3 FY2025Sep 30, 2025-$11.10M–
Q2 FY2025Jun 30, 2025-$15.99M–
Q1 FY2025Mar 31, 2025-$16.76M–
Q4 FY2024Dec 31, 2024-$52.52M–
Q3 FY2024Sep 30, 2024-$25.17M–
Q2 FY2024Jun 30, 2024-$524.00K–
Q1 FY2024Mar 31, 2024-$13.58M–
Q4 FY2023Dec 31, 2023-$4.84M–
Q3 FY2023Sep 30, 2023-$21.45M–
Q2 FY2023Jun 30, 2023-$23.96M–
Q1 FY2023Mar 31, 2023-$17.34M–
Q4 FY2022Dec 31, 2022-$9.59M-159.4%
Q3 FY2022Sep 30, 2022-$5.14M–
Q2 FY2022Jun 30, 2022-$62.83M-816.2%
Q1 FY2022Mar 31, 2022-$28.31M–
Q4 FY2021Dec 31, 2021$16.13M+125.4%
Q3 FY2021Sep 30, 2021-$13.07M–
Q2 FY2021Jun 30, 2021$8.77M+111.1%
Q1 FY2021Mar 31, 2021-$1.33M–
Q4 FY2020Dec 31, 2020$7.16M+30.4%
Q3 FY2020Sep 30, 2020-$6.94M–
Q2 FY2020Jun 30, 2020$4.16M–
Q1 FY2020Mar 31, 2020-$24.03M–
Q4 FY2019Dec 31, 2019$5.49M–
Q3 FY2019Sep 30, 2019-$4.52M–
Q2 FY2019Jun 30, 2019-$2.51M–
Q1 FY2019Mar 31, 2019-$22.74M–
Q4 FY2018Dec 31, 2018-$31.77M–
Q3 FY2018Sep 30, 2018-$22.25M–
Q2 FY2018Jun 30, 2018-$32.31M–
Q1 FY2018Mar 31, 2018-$21.90M–
Q4 FY2017Dec 31, 2017-$7.15M–
Q3 FY2017Sep 30, 2017-$8.45M–
Q2 FY2017Jun 30, 2017-$11.40M–
Q1 FY2017Mar 31, 2017-$18.56M–
Q4 FY2016Dec 31, 2016-$12.86M–

More Amarin figures

See a number that looks wrong?